Phase 1 Dose Escalation Study to Establish the Safety of Leukocyte Interleukin, Injection for Treatment of Perianal Warts in Adult Men and Women Who Are HIV/HPV Co-infected
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Buffy coat interleukins (Primary)
- Indications Condylomata acuminata
- Focus Therapeutic Use
- Sponsors CEL-SCI Corporation
- 23 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 18 Jul 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
- 18 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.